News
.png)
Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board
Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
%2520(1).jpeg)
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category
Lindus Health wins the 2025 Fierce CRO Award for Outstanding Patient Recruitment and Retention, highlighting the innovative use of our PIC technique.
Lindus Health Named a 2025 Fierce CRO Award Finalist in the Outstanding Patient Recruitment and Retention Category
Lindus Health has been shortlisted for the Fierce CRO Awards in the Outstanding Patient Recruitment and Retention Category
Lindus Health co-founder Meri Beckwith named on PM360's 2025 Elite 100
Meri Beckwith makes the PM360 Elite 100 for 2025.
Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design
Lindus Health has been awarded funding from ARIA to develop a groundbreaking AI-assisted clinical trial design system with built-in safety guarantees, in collaboration with the University of Oxford, aiming to make trials faster, more reliable, and scientifically rigorous.
Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD
Lindus Health and Sooma Medical are partnering on the development of a medical device to treat MDD.
Lindus Health and Tiefenbacher Group Launching Clinical Trial to Advance ME/CFS Research and Treatment
Lindus Health and Tiefenbacher Group have announced their clinical trial for ME/CFS.
Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research
Explore what this partnership means and how together, we're raising the bar for data standards across the industry.
Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
Learn more about how our Series B funding of $55 million supports our continued mission of bringing groundbreaking treatments to patients faster.